These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 14991492)

  • 21. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer biology in ulcerative colitis and potential use in endoscopic surveillance.
    Shapiro BD; Lashner BA
    Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):453-68. PubMed ID: 9177146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
    D'Haens GR; Lashner BA; Hanauer SB
    Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis.
    Lashner BA; Shapiro BD; Husain A; Goldblum JR
    Am J Gastroenterol; 1999 Feb; 94(2):456-62. PubMed ID: 10022646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
    Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts.
    Yoshida T; Mikami T; Mitomi H; Okayasu I
    J Pathol; 2003 Feb; 199(2):166-75. PubMed ID: 12533829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microsatellite instability and loss of heterozygosity in the nondysplastic colonic epithelium of ulcerative colitis.
    Takahashi S; Kojima Y; Kinouchi Y; Negoro K; Takagi S; Aihara H; Obana N; Matsumoto K; Hiwatashi N; Shimosegawa T
    J Gastroenterol; 2003; 38(8):734-9. PubMed ID: 14505126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of colorectal cancer in ulcerative colitis in India.
    Venkataraman S; Mohan V; Ramakrishna BS; Peter S; Chacko A; Chandy G; Kurian G; Kurian S; Mathan M; Mathan VI; Patra S; Pulimood A; Rolston DD
    J Gastroenterol Hepatol; 2005 May; 20(5):705-9. PubMed ID: 15853982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of colonic neoplasms and expressions of p53 and p21 proteins in experimental colitis of mice induced by dextran sulfate sodium.
    Takesue F; Korenaga D; Yao T; Kabashima A; Sugimachi K
    J Exp Clin Cancer Res; 2001 Sep; 20(3):413-8. PubMed ID: 11718223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
    Shin DM; Charuruks N; Lippman SM; Lee JJ; Ro JY; Hong WK; Hittelman WN
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):603-9. PubMed ID: 11401909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular alterations in chronic ulcerative colitis-associated and sporadic hyperplastic polyps: a comparative analysis.
    Odze RD; Brien T; Brown CA; Hartman CJ; Wellman A; Fogt F
    Am J Gastroenterol; 2002 May; 97(5):1235-42. PubMed ID: 12014733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk of colorectal cancer in ulcerative colitis--monitoring strategies and identification of risk patients].
    Porschen R; Strohmeyer G
    Z Gastroenterol; 1992 Sep; 30(9):585-93. PubMed ID: 1449007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis.
    Lindberg JO; Stenling RB; Rutegård JN
    Br J Surg; 1999 Jul; 86(7):947-50. PubMed ID: 10417571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.
    Velayos FS; Loftus EV; Jess T; Harmsen WS; Bida J; Zinsmeister AR; Tremaine WJ; Sandborn WJ
    Gastroenterology; 2006 Jun; 130(7):1941-9. PubMed ID: 16762617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
    Stenling R; Lindberg J; Rutegård J; Palmqvist R
    APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant correlation of morphological remodeling in ulcerative colitis with disease duration and between elevated p53 and p21 expression in rectal mucosa and neoplastic development.
    Mitsuhashi J; Mikami T; Saigenji K; Okayasu I
    Pathol Int; 2005 Mar; 55(3):113-21. PubMed ID: 15743319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
    Ozakyol A; Ozdemir M; Artan S
    Hepatogastroenterology; 2006; 53(68):192-5. PubMed ID: 16608022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.